Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Other Non-Current Assets (2016 - 2026)

SANUWAVE Health has reported Other Non-Current Assets over the past 16 years, most recently at $58000.0 for Q1 2026.

  • Quarterly Other Non-Current Assets changed N/A to $58000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $58000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $68000.0 for FY2025, N/A changed from the prior year.
  • Other Non-Current Assets was $58000.0 for Q1 2026 at SANUWAVE Health, down from $68000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $850000.0 in Q2 2023 and troughed at $58000.0 in Q1 2026.
  • The 4-year median for Other Non-Current Assets is $79000.0 (2025), against an average of $232200.0.
  • The largest YoY upside for Other Non-Current Assets was 60.89% in 2022 against a maximum downside of 60.89% in 2022.
  • A 4-year view of Other Non-Current Assets shows it stood at $106000.0 in 2022, then soared by 701.89% to $850000.0 in 2023, then crashed by 92.0% to $68000.0 in 2025, then fell by 14.71% to $58000.0 in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Other Non-Current Assets are $58000.0 (Q1 2026), $68000.0 (Q4 2025), and $79000.0 (Q3 2025).